JP2005247999A5
(enExample )
2007-03-01
EP2570434A3
(en )
2013-04-17
Neuropilin antagonists
JP2006517944A5
(enExample )
2007-04-05
JP2007500346A5
(enExample )
2007-08-30
JP2005507881A5
(enExample )
2005-12-22
WO2008074804A3
(en )
2008-08-07
Magnetic nanoparticles for the application in hyperthermia, preparation thereof and use in constructs having a pharmacological application
JP2008006269A5
(enExample )
2010-07-01
JP2005529870A5
(enExample )
2006-04-13
JP2009516717A5
(enExample )
2012-10-04
FR2873126B1
(fr )
2008-01-11
Nouveaux latex inverse a faible teneur en monomere a fonction acide fort, utilisation dans la fabrication de compositions topiques
EP1704853A3
(en )
2007-01-24
Water-in-silicone emulsion compositions
WO2007086967A3
(en )
2008-06-19
Small particle compositions and associated methods
JP2005522422A5
(enExample )
2006-03-16
USD508095S1
(en )
2005-08-02
Playhouse
JP2006505391A5
(enExample )
2006-12-07
EP2487182A3
(en )
2012-11-07
SP1 polypeptides, modified SP1 polypeptides and uses thereof
TWD113583S1
(zh )
2006-11-01
環繞音響塔
JP2009504909A5
(enExample )
2010-09-02
JP2009522138A5
(enExample )
2012-03-15
JP2008546803A5
(enExample )
2012-03-15
JP2003286377A5
(enExample )
2005-03-17
JP2004189991A5
(enExample )
2006-01-19
JP2009242695A5
(enExample )
2011-03-24
JP2004511237A5
(enExample )
2009-01-29
JP2004508310A5
(enExample )
2005-04-07